Research Associate Professor
Virginia Tech FBRI Cancer Research Center
Washington, District of Columbia, United States
Laura Dillon, PhD, FACMG is a Research Associate Professor at the Virginia Tech FBRI Cancer Research Center in Washington, DC. She received her BS from Virginia Tech in 2006 and her PhD from Wake Forest University in 2012. She completed a Postdoctoral Fellowship at the University of Virginia in 2015. In 2020 she completed the Medical Genetics and Genomic Medicine fellowship training program at the National Human Genome Research Institute and is ABMGG board-certified in Laboratory Genetics and Genomics. Dr. Dillon performs translational research focused on developing high sensitivity genomic tools for the detection of measurable residual disease in Acute Myeloid Leukemia patients after treatment, with the goal of predicting which patients may be at risk of relapse and whom may benefit from additional therapy.
Disclosure information not submitted.
Charting Residual Disease: From Molecular Markers to Liquid Biopsies
Wednesday, November 12, 2025
2:00 PM - 2:50 PM EST
(H054) Prospective Nationwide Evaluation of Whole Genome Sequencing for Acute Myeloid Leukemia
Saturday, November 15, 2025
1:45 PM - 2:00 PM EST